Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia

References

1. 1.↵
   1. Petcharunpaisan S,
   2. Ramalho J,
   3. Castillo M

   . Arterial spin-labeling in neuroimaging. World J Radiol 2010;2:384–98 doi:10.4329/wjr.v2.i10.384 pmid:21161024

   CrossRefPubMed
2. 2.↵
   1. Grade M,
   2. Hernandez Tamames JA,
   3. Pizzini FB, et al

   . A neuroradiologist’s guide to arterial spin-labeling MRI in clinical practice. Neuroradiology 2015;57:1181–1202 doi:10.1007/s00234-015-1571-z pmid:26351201

   CrossRefPubMed
3. 3.↵
   1. Wu C,
   2. Honarmand AR,
   3. Schnell S, et al

   . Age-related changes of normal cerebral and cardiac blood flow in children and adults aged 7 months to 61 years. J Am Heart Assoc 2016;5:e002657 doi:10.1161/JAHA.115.002657 pmid:26727967

   Abstract/FREE Full Text
4. 4.↵
   1. Bangen KJ,
   2. Nation DA,
   3. Clark LR, et al

   . Interactive effects of vascular risk burden and advanced age on cerebral blood flow. Front Aging Neurosci 2014;6:159 doi:10.3389/fnagi.2014.00159 pmid:25071567

   CrossRefPubMed
5. 5.↵
   1. Pantoni L,
   2. Poggesi A,
   3. Inzitari D

   . Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts. Cerebrovasc Dis 2009;27 Suppl 1:191–96 doi:10.1159/000200459 pmid:19342851

   CrossRefPubMed
6. 6.↵
   1. Gyanwali B,
   2. Shaik MA,
   3. Tan CS, et al

   . Mixed-location cerebral microbleeds as a biomarker of neurodegeneration in a memory clinic population. Aging 2019;11:10581–96 doi:10.18632/aging.102478 pmid:31767809

   CrossRefPubMed
7. 7.↵
   1. Charidimou A,
   2. Boulouis G,
   3. Pasi M, et al

   . MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2017;88:1157–64 doi:10.1212/WNL.0000000000003746 pmid:28228568

   Abstract/FREE Full Text
8. 8.↵
   1. Bastos-Leite AJ,
   2. Kuijer JP,
   3. Rombouts SA, et al

   . Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29:1296–1301 doi:10.3174/ajnr.A1091 pmid:18451090

   CrossRefPubMed
9. 9.↵
   1. Hashimoto T,
   2. Yokota C,
   3. Koshino K, et al

   . Cerebral blood flow and metabolism associated with cerebral microbleeds in small vessel disease. Ann Nucl Med 2016;30:494–500 doi:10.1007/s12149-016-1086-7 pmid:27246951

   CrossRefPubMed
10. 10.↵
    1. Doi H,
    2. Inamizu S,
    3. Saito B-Y, et al

    . Analysis of cerebral lobar microbleeds and a decreased cerebral blood flow in a memory clinic setting. Intern Med 2015;54:1027–33 doi:10.2169/internalmedicine.54.3747 pmid:25948342

    CrossRefPubMed
11. 11.↵
    1. Thamm T,
    2. Zweynert S,
    3. Piper SK, et al

    . Diagnostic and prognostic benefit of arterial spin labeling in subacute stroke. Brain Behav 2019;9:e01271 doi:10.1002/brb3.1271 pmid:30912272

    CrossRefPubMed
12. 12.↵
    1. Zaharchuk G

    . Arterial spin-labeled perfusion imaging in acute ischemic stroke. Stroke 2014;45:1202–07 doi:10.1161/STROKEAHA.113.003612 pmid:24603069

    FREE Full Text
13. 13.↵
    1. Riederer I,
    2. Bohn KP,
    3. Preibisch C, et al

    . Alzheimer disease and mild cognitive impairment: integrated pulsed arterial spin-labeling MRI and 18F-FDG PET. Radiology 2018;288:198–206 doi:10.1148/radiol.2018170575 pmid:29762090

    CrossRefPubMed
14. 14.↵
    1. Schuff N,
    2. Matsumoto S,
    3. Kmiecik J, et al

    . Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 2009;5:454–62 doi:10.1016/j.jalz.2009.04.1233 pmid:19896584

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Sun Y,
    2. Cao W,
    3. Ding W, et al

    . Cerebral blood flow alterations as assessed by 3D ASL in cognitive impairment in patients with subcortical vascular cognitive impairment: a marker for disease severity. Front Aging Neurosci 2016;8:211 doi:10.3389/fnagi.2016.00211 pmid:27630562

    CrossRefPubMed
16. 16.↵
    1. Mutsaerts HJ,
    2. Petr J,
    3. Václavů L, et al

    . The spatial coefficient of variation in arterial spin-labeling cerebral blood flow images. J Cereb Blood Flow Metab 2017;37:3184–92 doi:10.1177/0271678X16683690 pmid:28058975

    CrossRefPubMed
17. 17.↵
    1. Hilal S,
    2. Mok V,
    3. Youn YC, et al

    . Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry 2017;88:669–74 doi:10.1136/jnnp-2016-315324 pmid:28600443

    Abstract/FREE Full Text
18. 18.↵
    1. Wardlaw JM,
    2. Smith EE,
    3. Biessels GJ

    , et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38 doi:10.1016/S1474-4422(13)70124-8 pmid:23867200

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Mutsaerts HJ,
    2. Petr J,
    3. Groot P, et al

    . ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage 2020;219:117031 doi:10.1016/j.neuroimage.2020.117031 pmid:32526385

    CrossRefPubMed
20. 20.↵
    1. Skurdal MJ,
    2. Bjørnerud A,
    3. van Osch MJ, et al

    . Voxel-wise perfusion assessment in cerebral white matter with PCASL at 3T: is it possible and how long does it take? PLoS One 2015;10:e0135596 doi:10.1371/journal.pone.0135596 pmid:26267661

    CrossRefPubMed
21. 21.↵
    1. El Assar M,
    2. Angulo J,
    3. Vallejo S, et al

    . Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol 2012;3:132 doi:10.3389/fphys.2012.00132 pmid:22783194

    CrossRefPubMed
22. 22.↵
    1. Wagner M,
    2. Jurcoane A,
    3. Volz S, et al

    . Age-related changes of cerebral autoregulation: new insights with quantitative T2′-mapping and pulsed arterial spin-labeling MR imaging. AJNR Am J Neuroradiol 2012;33:2081–88 doi:10.3174/ajnr.A3138 pmid:22700750

    Abstract/FREE Full Text
23. 23.↵
    1. Thore CR,
    2. Anstrom JA,
    3. Moody DM, et al

    . Morphometric analysis of arteriolar tortuosity in human cerebral white matter of preterm, young, and aged subjects. J Neuropathol Exp Neurol 2007;66:337–45 doi:10.1097/nen.0b013e3180537147 pmid:17483690

    CrossRefPubMed
24. 24.↵
    1. Xu X,
    2. Wang B,
    3. Ren C, et al

    . Age-related impairment of vascular structure and functions. Aging Dis 2017;8:590–610 doi:10.14336/AD.2017.0430 pmid:28966804

    CrossRefPubMed
25. 25.↵
    1. Cosgrove KP,
    2. Mazure CM,
    3. Staley JK

    . Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 2007;62:847–55 doi:10.1016/j.biopsych.2007.03.001 pmid:17544382

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Suzuki S,
    2. Brown CM,
    3. Wise PM

    . Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol 2009;30:201–11 doi:10.1016/j.yfrne.2009.04.007 pmid:19401209

    CrossRefPubMedWeb of Science
27. 27.↵
    1. de la Torre JC

    . Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012;2012:367516 doi:10.1155/2012/367516 pmid:23243502

    CrossRefPubMed
28. 28.↵
    1. Ramchandra R,
    2. Barrett CJ,
    3. Malpas SC

    . Nitric oxide and sympathetic nerve activity in the control of blood pressure. Clin Exp Pharmacol Physiol 2005;32:440–46 doi:10.1111/j.1440-1681.2005.04208.x pmid:15854155

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Meyer JS,
    2. Rogers RL,
    3. Mortel KF, et al

    . Hyperlipidemia is a risk factor for decreased cerebral perfusion and stroke. Arch Neurol 1987;44:418–22 doi:10.1001/archneur.1987.00520160052014 pmid:3827697

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Yaghi S,
    2. Elkind MS

    . Lipids and cerebrovascular disease: research and practice. Stroke 2015;46:3322–28 doi:10.1161/STROKEAHA.115.011164 pmid:26451029

    FREE Full Text
31. 31.↵
    1. Redgrave JN,
    2. Lovett JK,
    3. Rothwell PM

    . Histological features of symptomatic carotid plaques in relation to age and smoking: the Oxford plaque study. Stroke 2010;41:2288–94 doi:10.1161/STROKEAHA.110.587006 pmid:20814007

    Abstract/FREE Full Text
32. 32.↵
    1. Powell JT

    . Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998;3:21–28 doi:10.1177/1358836X9800300105 pmid:9666528

    CrossRefPubMed
33. 33.↵
    1. Mishra RK,
    2. Li Y,
    3. Ricardo AC, et al

    . Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol 2013;111:432–38 doi:10.1016/j.amjcard.2012.10.019 pmid:23178053

    CrossRefPubMed
34. 34.↵
    1. Kim W,
    2. Kim EJ

    . Heart failure as a risk factor for stroke. J Stroke 2018;20:33–45 doi:10.5853/jos.2017.02810 pmid:29402070

    CrossRefPubMed
35. 35.↵
    1. Schreiber S,
    2. Bueche CZ,
    3. Garz C, et al

    . The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase? J Cereb Blood Flow Metab 2012;32:278–90 doi:10.1038/jcbfm.2011.122 pmid:21878945

    CrossRefPubMed
36. 36.↵
    1. Gyanwali B,
    2. Vrooman H,
    3. Venketasubramanian N, et al

    . Cerebral small vessel disease and enlarged perivascular spaces-data from memory clinic and population-based settings. Front Neurol 2019;10:669 doi:10.3389/fneur.2019.00669 pmid:31293506

    CrossRefPubMed
37. 37.↵
    1. Francis F,
    2. Ballerini L,
    3. Wardlaw JM

    . Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: a systematic review and meta-analysis. Int J Stroke 2019;14:359–71 doi:10.1177/1747493019830321 pmid:30762496

    CrossRefPubMed
38. 38.↵
    1. Bouvy WH,
    2. Zwanenburg JJ,
    3. Reinink R, et al

    ; Utrecht Vascular Cognitive Impairment (VCI) Study Group. Perivascular spaces on 7 Tesla brain MRI are related to markers of small vessel disease but not to age or cardiovascular risk factors. J Cereb Blood Flow Metab 2016;36:1708–17 doi:10.1177/0271678X16648970 pmid:27154503

    CrossRefPubMed
39. 39.↵
    1. Kalaria RN

    . Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev 2010;68 Suppl 2:S74–87 doi:10.1111/j.1753-4887.2010.00352.x pmid:21091952

    CrossRefPubMed
40. 40.↵
    1. ElAli A,
    2. Thériault P,
    3. Préfontaine P, et al

    . Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation. Acta Neuropathol Commun 2013;1:75–75 doi:10.1186/2051-5960-1-75 pmid:24252187

    CrossRefPubMed
41. 41.↵
    1. Beason-Held LL,
    2. Goh JO,
    3. An Y, et al

    . Changes in brain function occur years before the onset of cognitive impairment. J Neurosci 2013;33:18008–14 doi:10.1523/JNEUROSCI.1402-13.2013 pmid:24227712

    Abstract/FREE Full Text
42. 42.↵
    1. van Osch MJ,
    2. Teeuwisse WM,
    3. van Walderveen MA, et al

    . Can arterial spin-labeling detect white matter perfusion signal? Magn Reson Med 2009;62:165–73 doi:10.1002/mrm.22002 pmid:19365865

    CrossRefPubMed
43. 43.↵
    1. Keil VC,
    2. Eichhorn L,
    3. Mutsaerts H, et al

    . Cerebrovascular reactivity during prolonged breath-hold in experienced freedivers. AJNR Am J Neuroradiol 2018;39:1839–47 doi:10.3174/ajnr.A5790 pmid:30237299

    Abstract/FREE Full Text